Company

Junshi Biosciences Doses First Patient in Pivotal Phase III Trial of JS207 Plus JS007 Versus Toripalimab‑Bevacizumab in Advanced Hepatocellular Carcinoma
Clinical trial approval / initiationHKG: 1877

Junshi Biosciences Doses First Patient in Pivotal Phase III Trial of JS207 Plus JS007 Versus Toripalimab‑Bevacizumab in Advanced Hepatocellular Carcinoma

Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877; SHA: 688180) announced that first patient dosing has been completed in the multi‑center, randomized, controlled, open‑label Phase III JS207‑017‑III‑HCC study (NCT07823348), evaluating JS207…

Shanghai Pharmaceuticals Renews Sales and Distribution Agreement with Fudan‑Zhangjiang Through 2029 Under RMB 272 Million Caps

Shanghai Pharmaceuticals Renews Sales and Distribution Agreement with Fudan‑Zhangjiang Through 2029 Under RMB 272 Million Caps

Gilead Q3 Product Sales Jump 13% to USD 8.3 Billion as HIV Franchise Grows 18%; Full‑Year Guidance Raised to USD 31.0–31.3 Billion

Gilead Q3 Product Sales Jump 13% to USD 8.3 Billion as HIV Franchise Grows 18%; Full‑Year Guidance Raised to USD 31.0–31.3 Billion

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Sansure Biotech's Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification
CVDProduct approvals

Sansure Biotech’s Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification

Biogen's Zurzuvae Receives Positive CHMP Opinion for Postpartum Depression Treatment
BiogenMarket approval filings

Biogen’s Zurzuvae Receives Positive CHMP Opinion for Postpartum Depression Treatment

Sanofi's Sarclisa Approved in EU for Newly Diagnosed Multiple Myeloma
CancerNASDAQ: SNY

Sanofi’s Sarclisa Approved in EU for Newly Diagnosed Multiple Myeloma

Velavigo Closes $60 Million Pre-A+ Financing Round to Advance Global Clinical Trials
FinanceVelaVigo

Velavigo Closes $60 Million Pre-A+ Financing Round to Advance Global Clinical Trials

Show More